Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors.

× No keyword cloud information.

45 in total

1. The role of metal binding and phosphorylation domains in the regulation of cisplatin-induced trafficking of ATP7B.

Authors: Roohangiz Safaei; Preston L Adams; Ryan A Mathews; Gerald Manorek; Stephen B Howell
Journal: Metallomics Date: 2013-08 Impact factor: 4.526

2. Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.

Authors: Michael G Woo; Kai Xue; Jiayin Liu; Heidi McBride; Benjamin K Tsang
Journal: J Biol Chem Date: 2011-11-23 Impact factor: 5.157

3. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.

Authors: Xiying Shang; Xinjian Lin; Edwin Alvarez; Gerald Manorek; Stephen B Howell
Journal: Neoplasia Date: 2012-10 Impact factor: 5.715

4. Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1.

Authors: Danielle D Jandial; Salman Farshchi-Heydari; Christopher A Larson; Gregory I Elliott; Wolfgang J Wrasidlo; Stephen B Howell
Journal: Clin Cancer Res Date: 2009-01-15 Impact factor: 12.531

5. Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.

Authors: Danielle D Jandial; Karen Messer; Salman Farshchi-Heydari; Minya Pu; Stephen B Howell
Journal: Gynecol Oncol Date: 2009-09-22 Impact factor: 5.482

6. In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.

Authors: R D Christen; A P Jekunen; J A Jones; F Thiebaut; D R Shalinsky; S B Howell
Journal: J Clin Invest Date: 1993-07 Impact factor: 14.808

Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors.

1. The role of metal binding and phosphorylation domains in the regulation of cisplatin-induced trafficking of ATP7B.

2. Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.

3. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.

4. Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1.

5. Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.

6. In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.

7. Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line.

8. DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.

9. Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

10. The onco-embryonic antigen ROR1 is expressed by a variety of human cancers.